First Myeloma Patient in Study Treated with New CAR T-Cell Therapy bb21217 – Myeloma Research News
Myeloma Research News |
First Myeloma Patient in Study Treated with New CAR T-Cell Therapy bb21217
Myeloma Research News The therapy belongs to the class of CAR T-cell therapies, where the immune T-cells are collected from a patient and then re-engineered in a laboratory to produce chimeric antigen receptors (CARs) that will more effectively recognize tumor cells. |
